Aclaris Therapeutics, Inc. (ACRS)
Pharmaceutical Preparations
Latest Price
$5.32
TTM P/E
--
Normalized P/E
--
Div Yield
--
Book Value
0.92
P/B Ratio
5.80
Institutional Ownership
84.0% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 12.72M | $67.0M | 9.10% | +5.92M | 2026-06-30 |
| BML Capital Management, LLC | 11.97M | $63.0M | 8.56% | -2.27M | 2026-06-30 |
| BlackRock, Inc. | 10.04M | $53.0M | 7.18% | +2.63M | 2026-06-30 |
| Deep Track Capital, LP | 9.35M | $49.0M | 6.68% | -- | 2026-06-30 |
| Vivo Capital, LLC | 6.69M | $35.0M | 4.79% | +28.0K | 2026-06-30 |
| VANGUARD CAPITAL MANAGEMENT LLC | 5.82M | $30.0M | 4.16% | +650.4K | 2026-06-30 |
| Frazier Life Sciences Management, L.P. | 4.93M | $26.0M | 3.52% | -- | 2026-06-30 |
| Rock Springs Capital Management LP | 4.33M | $22.0M | 3.10% | -142.1K | 2026-06-30 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 4.07M | $21.0M | 2.91% | +200.0K | 2026-06-30 |
| Decheng Capital LLC | 4.04M | $21.0M | 2.89% | -- | 2026-06-30 |